These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 22243802

  • 1. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
    Su FY, Lin KJ, Sonaje K, Wey SP, Yen TC, Ho YC, Panda N, Chuang EY, Maiti B, Sung HW.
    Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
    [Abstract] [Full Text] [Related]

  • 2. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery.
    Chuang EY, Lin KJ, Su FY, Chen HL, Maiti B, Ho YC, Yen TC, Panda N, Sung HW.
    J Control Release; 2013 Aug 10; 169(3):296-305. PubMed ID: 23195534
    [Abstract] [Full Text] [Related]

  • 3. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
    Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, Hsu CW, Yen TC, Juang JH, Sung HW.
    Biomaterials; 2010 Sep 10; 31(26):6849-58. PubMed ID: 20619787
    [Abstract] [Full Text] [Related]

  • 4. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH, Sonaje K, Lin KM, Juang JH, Mi FL, Yang HW, Sung HW.
    J Control Release; 2008 Dec 08; 132(2):141-9. PubMed ID: 18817821
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
    Chuang EY, Nguyen GT, Su FY, Lin KJ, Chen CT, Mi FL, Yen TC, Juang JH, Sung HW.
    Biomaterials; 2013 Oct 08; 34(32):7994-8001. PubMed ID: 23891516
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW.
    Biomacromolecules; 2007 Jan 08; 8(1):146-52. PubMed ID: 17206800
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
    Chuang EY, Lin KJ, Su FY, Mi FL, Maiti B, Chen CT, Wey SP, Yen TC, Juang JH, Sung HW.
    J Control Release; 2013 Dec 10; 172(2):513-22. PubMed ID: 23702234
    [Abstract] [Full Text] [Related]

  • 8. Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles.
    Su FY, Chuang EY, Lin PY, Chou YC, Chen CT, Mi FL, Wey SP, Yen TC, Lin KJ, Sung HW.
    Biomaterials; 2014 Apr 10; 35(11):3641-9. PubMed ID: 24477192
    [Abstract] [Full Text] [Related]

  • 9. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A, Tozuka Y, Takeuchi H.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):445-51. PubMed ID: 21182939
    [Abstract] [Full Text] [Related]

  • 10. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins.
    Sonaje K, Lin KJ, Tseng MT, Wey SP, Su FY, Chuang EY, Hsu CW, Chen CT, Sung HW.
    Biomaterials; 2011 Nov 18; 32(33):8712-21. PubMed ID: 21862121
    [Abstract] [Full Text] [Related]

  • 11. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
    Nguyen HN, Wey SP, Juang JH, Sonaje K, Ho YC, Chuang EY, Hsu CW, Yen TC, Lin KJ, Sung HW.
    Biomaterials; 2011 Apr 18; 32(10):2673-82. PubMed ID: 21256586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR, Sharma CP.
    J Control Release; 2009 Apr 17; 135(2):144-51. PubMed ID: 19331862
    [Abstract] [Full Text] [Related]

  • 15. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ.
    Int J Pharm; 2012 Apr 04; 425(1-2):1-8. PubMed ID: 22248666
    [Abstract] [Full Text] [Related]

  • 16. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]

  • 17. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 18. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
    Chen MC, Wong HS, Lin KJ, Chen HL, Wey SP, Sonaje K, Lin YH, Chu CY, Sung HW.
    Biomaterials; 2009 Dec 01; 30(34):6629-37. PubMed ID: 19767097
    [Abstract] [Full Text] [Related]

  • 19. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
    Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW.
    Biomaterials; 2009 Apr 01; 30(12):2329-39. PubMed ID: 19176244
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.